Holocene Advisors’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40M | Sell |
326,095
-141,060
| -30% | -$17.3M | 0.1% | 189 |
|
|
2025
Q1 | $47.3M | Buy |
467,155
+547
| +0.1% | +$55.4K | 0.14% | 168 |
|
|
2024
Q4 | $43.1M | Sell |
466,608
-15,043
| -3% | -$1.39M | 0.14% | 171 |
|
|
2024
Q3 | $46.5M | Sell |
481,651
-161,147
| -25% | -$15.6M | 0.19% | 154 |
|
|
2024
Q2 | $55.1M | Buy |
642,798
+57,424
| +10% | +$4.93M | 0.23% | 130 |
|
|
2024
Q1 | $48.3M | Sell |
585,374
-235,609
| -29% | -$19.5M | 0.18% | 150 |
|
|
2023
Q4 | $54.8M | Buy |
820,983
+188,175
| +30% | +$12.6M | 0.21% | 143 |
|
|
2023
Q3 | $42.5M | Buy |
632,808
+58,637
| +10% | +$3.94M | 0.19% | 151 |
|
|
2023
Q2 | $38.9M | Buy |
574,171
+556,060
| +3,070% | +$37.7M | 0.17% | 152 |
|
|
2023
Q1 | $980K | Sell |
18,111
-287,018
| -94% | -$15.5M | ﹤0.01% | 581 |
|
|
2022
Q4 | $18.2M | Buy |
305,129
+266,104
| +682% | +$15.9M | 0.11% | 190 |
|
|
2022
Q3 | $1.77M | Buy |
+39,025
| New | +$1.77M | 0.01% | 464 |
|
|
2022
Q2 | – | Sell |
-117,037
| Closed | -$6.62M | – | 867 |
|
|
2022
Q1 | $6.62M | Sell |
117,037
-41,079
| -26% | -$2.32M | 0.03% | 249 |
|
|
2021
Q4 | $8.21M | Buy |
158,116
+29,468
| +23% | +$1.53M | 0.04% | 239 |
|
|
2021
Q3 | $7.68M | Buy |
128,648
+38,136
| +42% | +$2.28M | 0.04% | 256 |
|
|
2021
Q2 | $5.62M | Buy |
90,512
+36,819
| +69% | +$2.29M | 0.03% | 307 |
|
|
2021
Q1 | $3.5M | Buy |
53,693
+35,329
| +192% | +$2.3M | 0.02% | 462 |
|
|
2020
Q4 | $1.21M | Buy |
18,364
+6,680
| +57% | +$439K | 0.01% | 491 |
|
|
2020
Q3 | $604K | Buy |
11,684
+2,984
| +34% | +$154K | ﹤0.01% | 536 |
|
|
2020
Q2 | $429K | Buy |
+8,700
| New | +$429K | ﹤0.01% | 517 |
|
|
2019
Q3 | – | Sell |
-7,137
| Closed | -$360K | – | 732 |
|
|
2019
Q2 | $360K | Buy |
+7,137
| New | +$360K | ﹤0.01% | 532 |
|